Skip to content

Firm Record

Barclay Luke & Pillai Specialty Pharmacy PLLC dba Meta Pharmacy Services

27 findings from 3 inspection documents published by regulators. Each row below says what its date means.

US FDA · 2019-04-30 ~ 2024-01-17

Areas cited

Laboratory and QC controlsTraining and personnelAseptic processing and sterility assuranceDocumentation and recordsEquipment and facilityStability and storageMaterial and supplier controlContamination controlDeviation, CAPA, and investigationQuality unit oversightEnvironmental monitoring

Published inspection documents

21 CFR sections cited in FDA inspections

Citations from 1 FDA inspection (2022-12-09) of facilities listed under this company name in FDA's inspection citation data.

As written by FDAInspectionLatest inspection
21 CFR 211.165(a)Testing and release for distribution12022-12-09
21 CFR 211.84(d)(1)Identity Testing of Each Component12022-12-09

1 site: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC (Las Vegas, NV, United States) · 1 inspection

Source: FDA Data Dashboard - Inspections Citations, as of 2026-11-08. Only inspections with at least one citation are included, and a section cited more than once in one inspection counts once. Only facilities whose name and legal form match this page's documents, and that are listed in a single country, are included.

Other companies with similar findings

Other companies with findings worded closely to this company's. Only documents of the same type are compared.

A record as of publication. Check the agency's own announcements for any later corrective action.

What is included. As collected on 2026-11-15: only documents with a detail page (3 or more findings). See the firm lookup for everything.

Full history of Barclay Luke & Pillai Specialty Pharmacy PLLC dba Meta Pharmacy Services — including inspection classifications Browse by document Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.